{
  "question_stem": {
    "en": "A 64-year-old man comes to the office due to slowing of his movements and gait instability that has contributed to several recent falls. The patient was diagnosed with Parkinson disease a year ago. On physical examination, there is a resting tremor involving the right hand and rigidity during passive flexion and extension of the right upper limb. The patient is started on therapy with pramipexole. Which of the following best describes the mechanism of action of this medication?",
    "zh": "一名64岁男性因行动迟缓和步态不稳前来就诊，这些症状导致他最近多次跌倒。患者一年前被诊断为帕金森病。体格检查显示，患者右手出现静止性震颤，被动屈伸右侧上肢时出现僵硬。患者开始接受普拉克索治疗。以下哪项最好地描述了该药物的作用机制？"
  },
  "question": {
    "en": "Which of the following best describes the mechanism of action of this medication?",
    "zh": "以下哪项最好地描述了该药物的作用机制？"
  },
  "options": {
    "A": {
      "en": "Decreases central dopamine degradation",
      "zh": "减少中枢多巴胺降解"
    },
    "B": {
      "en": "Directly stimulates dopamine receptors",
      "zh": "直接刺激多巴胺受体"
    },
    "C": {
      "en": "Enhances the effect of endogenous dopamine",
      "zh": "增强内源性多巴胺的作用"
    },
    "D": {
      "en": "Increases dopamine precursor availability in the brain",
      "zh": "增加大脑中多巴胺前体的可用性"
    },
    "E": {
      "en": "Inhibits central muscarinic receptors",
      "zh": "抑制中枢毒蕈碱受体"
    }
  },
  "correct_answer": "B",
  "explanation": {
    "en": "This patient has Parkinson disease (PD), which is caused by degeneration of the dopaminergic neurons in the substantia nigra, leading to a progressive deficiency of dopamine available to inhibit the basal ganglia. This results in decreased stimulation of the motor cortex by the thalamus, leading to the classic triad of bradykinesia, rigidity, and resting tremor.\n\nSeveral categories of medications used for PD aim to treat dopamine insufficiency by different mechanisms:\n\n* Dopamine precursors (eg, levodopa) replace dopamine depletion\n* Enzyme inhibitors (eg, selegiline) inhibit central dopamine degradation\n* Dopamine agonists (eg, pramipexole) directly activate dopamine receptors\n\nDopamine agonists (eg, pramipexole) have a chemical structure similar to that of the neurotransmitter dopamine and directly stimulate dopamine receptors. Unlike levodopa, they do not have to be metabolized to be active. In addition to having similar adverse effects as levodopa (eg, nausea, orthostasis), dopamine agonists' direct stimulation of dopamine receptors can cause impulse control disorders (eg, pathologic gambling, compulsive sexuality), likely because dopamine is involved in the rewards pathway.\n\n(Choice A) Selegiline inhibits monoamine oxidase-B in the brain, which results in decreased central dopamine degradation, leaving more available to stimulate the basal ganglia.\n\n(Choice C) Amantadine enhances the effect of endogenous dopamine by increasing dopamine release and inhibiting its reuptake. It is also thought to cause anticholinergic effects (reduces tremor), as well as antagonism of N-methyl-D-aspartate receptors (reduces glutamine-induced neurotoxicity).\n\n(Choice D) Both catechol-O-methyltransferase inhibitors (eg, entacapone, tolcapone) and dopa decarboxylase inhibitors (eg, carbidopa) decrease the breakdown of levodopa in peripheral tissues and increase the amount of levodopa available to cross the blood-brain barrier.\n\n(Choice E) The dopamine insufficiency of PD upsets the normal balance between dopamine and acetylcholine in the basal ganglia, resulting in cholinergic hypersensitivity. Anticholinergic medications (eg, trihexyphenidyl) counteract this effect by inhibiting central muscarinic receptors. These drugs are typically limited to younger patients with tremor-dominant PD due to adverse effects in the elderly and lack of effect on bradykinesia/rigidity.\n\nEducational objective:\nDopamine agonists have a chemical structure similar to that of the neurotransmitter dopamine and directly stimulate dopamine receptors. They can be used instead of, or in addition to, levodopa therapy to treat the motor symptoms of Parkinson disease (eg, bradykinesia, rigidity, tremor).",
    "zh": "该患者患有帕金森病 (PD)，病因是黑质多巴胺能神经元的变性，导致可抑制基底神经节的多巴胺进行性缺乏。这导致丘脑对运动皮层的刺激减少，从而导致运动迟缓、僵硬和静止性震颤的经典三联征。\n\n用于 PD 的几种药物类别旨在通过不同的机制治疗多巴胺不足：\n\n* 多巴胺前体（例如，左旋多巴）替代多巴胺耗竭\n* 酶抑制剂（例如，司来吉兰）抑制中枢多巴胺降解\n* 多巴胺激动剂（例如，普拉克索）直接激活多巴胺受体\n\n多巴胺激动剂（例如，普拉克索）具有与神经递质多巴胺相似的化学结构，并直接刺激多巴胺受体。与左旋多巴不同，它们不必被代谢即可发挥活性。除了具有与左旋多巴相似的不良反应（例如，恶心、直立性低血压）外，多巴胺激动剂直接刺激多巴胺受体还可引起冲动控制障碍（例如，病理性赌博、强迫性性行为），这可能是因为多巴胺参与奖励通路。\n\n(选项 A) 司来吉兰抑制大脑中的单胺氧化酶-B，这导致中枢多巴胺降解减少，从而留下更多的多巴胺来刺激基底神经节。\n\n(选项 C) 金刚烷胺通过增加多巴胺释放并抑制其再摄取来增强内源性多巴胺的作用。它也被认为会引起抗胆碱能作用（减少震颤），以及对 N-甲基-D-天冬氨酸受体（减少谷氨酰胺诱导的神经毒性）的拮抗作用。\n\n(选项 D) 两种儿茶酚-O-甲基转移酶抑制剂（例如，恩他卡朋、托卡朋）和多巴脱羧酶抑制剂（例如，卡比多巴）均可减少左旋多巴在外周组织中的分解，并增加可穿过血脑屏障的左旋多巴量。\n\n(选项 E) PD 的多巴胺不足破坏了基底神经节中多巴胺和乙酰胆碱之间的正常平衡，导致胆碱能高敏性。抗胆碱能药物（例如，苯海索）通过抑制中枢毒蕈碱受体来抵消这种作用。由于对老年人的不良反应以及对运动迟缓/僵硬的无作用，这些药物通常仅限于震颤为主的 PD 的年轻患者。\n\n教育目标：\n多巴胺激动剂具有与神经递质多巴胺相似的化学结构，并直接刺激多巴胺受体。它们可以代替或补充左旋多巴治疗来治疗帕金森病的运动症状（例如，运动迟缓、僵硬、震颤）。"
  },
  "summary": {
    "en": "This question tests the understanding of the pharmacological mechanisms of drugs used to treat Parkinson disease, specifically focusing on dopamine agonists. It requires knowledge of how different drug classes address dopamine deficiency in the brain.\n\nTo solve this question, identify the drug class of pramipexole (dopamine agonist) and recall its primary mechanism of action, which is direct stimulation of dopamine receptors, differentiating it from other Parkinson's medications like MAO-B inhibitors or COMT inhibitors.",
    "zh": "本题测试对用于治疗帕金森病的药物的药理学机制的理解，特别侧重于多巴胺激动剂。它需要了解不同的药物类别如何解决大脑中的多巴胺缺乏症。\n\n要解决这个问题，请确定普拉克索（多巴胺激动剂）的药物类别，并回忆其主要作用机制，即直接刺激多巴胺受体，将其与其他帕金森病药物（如 MAO-B 抑制剂或 COMT 抑制剂）区分开来。"
  },
  "tags": "Parkinson disease; Dopamine agonists; Pramipexole; Dopamine receptors; Bradykinesia; Rigidity; Tremor; Pharmacology; Neurology",
  "category": "Neuro",
  "question_id": "703",
  "has_exhibits": true,
  "exhibit_count": 2,
  "exhibit_files": [
    "image1.jpg",
    "image2.jpg"
  ],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Neuro 23\\703",
  "extracted_at": "2025-11-05T19:29:29.721770",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 2,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T18:28:16.310774",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}